Lithium Ion

Lithium Ion

SCHEMBL188290

[Li+].[Li+].[O-]B([O-])Oc1ccccc1

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Lithium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 3/20 0.43
TSHR P16473 1/20 0.43
CA4 P22748 1/20 0.39
KCNA3 P22001 1/20 0.36
CA5A P35218 1/20 0.35
CA5B Q9Y2D0 1/20 0.35
CA1 P00915 2/20 0.34
CA2 P00918 2/20 0.34
NR1H2 P55055 1/20 0.33
BAX Q07812 1/20 0.33
MAOA P21397 1/20 0.33
SOS1 Q07889 1/20 0.32
LMNA P02545 1/20 0.32
GAA P10253 1/20 0.32
KMT2A Q03164 1/20 0.32
TAAR1 Q96RJ0 1/20 0.32
ALDH1A1 P00352 1/20 0.32
RECQL P46063 1/20 0.32
CA9 Q16790 1/20 0.32
SRC P12931 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Lithium Ion SCHEMBL28887480 1.00 LTA4H (0.43) LTA4HTSHRCA4KCNA3CA5A
SCHEMBL188076 0.94 LTA4H (0.43) LTA4HTSHRCA4KCNA3CA5A
SCHEMBL29232696 0.94 LTA4H (0.43) LTA4HTSHRCA4KCNA3CA5A
SCHEMBL29118344 0.94 LTA4H (0.43) LTA4HTSHRCA4KCNA3CA5A
Potassium Ion SCHEMBL187986 0.94 LTA4H (0.43) LTA4HTSHRCA4KCNA3CA5A
SCHEMBL31538469 0.94 LTA4H (0.43) LTA4HTSHRCA4KCNA3CA5A
SCHEMBL414391 0.94 LTA4H (0.43) LTA4HTSHRCA4KCNA3CA5A
SCHEMBL187417 0.94 LTA4H (0.43) LTA4HTSHRCA4KCNA3CA5A
SCHEMBL29213652 0.94 LTA4H (0.43) LTA4HTSHRCA4KCNA3CA5A
SCHEMBL28459811 0.94 LTA4H (0.43) LTA4HTSHRCA4KCNA3CA5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 154 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115117453-B Electrolyte for lithium metal secondary battery 武汉大学 2024-09-10 CN claimed
CN-115117453-A Electrolyte for lithium metal secondary battery 武汉大学 2022-09-27 CN claimed
US-9673485-B2 Anode of cable-type secondary battery and manufacturing method thereof LG CHEM, LTD. (KR) 2017-06-06 US claimed
EP-2631963-B1 CABLE-TYPE SECONDARY BATTERY LG CHEMICAL LTD (KR) 2016-05-18 EP claimed
EP-2631970-B1 CATHODE FOR CABLE-TYPE SECONDARY BATTERY AND METHOD FOR MANUFACTURING SAME LG CHEMICAL LTD (KR) 2016-01-13 EP claimed
EP-2637244-B1 CABLE TYPE RECHARGEABLE BATTERY AND MANUFACTURING METHOD THEREOF LG CHEMICAL LTD (KR) 2014-12-03 EP claimed
US-8748032-B2 Cable-type secondary battery LG CHEM, LTD. (KR) 2014-06-10 US claimed
US-8617258-B2 Cable-type secondary battery and manufacturing method thereof LG CHEM, LTD. (KR) 2013-12-31 US claimed
EP-2637244-A2 CABLE TYPE RECHARGEABLE BATTERY AND MANUFACTURING METHOD THEREOF LG Chem, Ltd. (KR) 2013-09-11 EP claimed
EP-2631963-A2 CABLE-TYPE SECONDARY BATTERY LG Chem, Ltd. (KR) 2013-08-28 EP claimed
EP-2631970-A2 CATHODE FOR CABLE-TYPE SECONDARY BATTERY AND METHOD FOR MANUFACTURING SAME LG Chem, Ltd. (KR) 2013-08-28 EP claimed
US-8486558-B2 Cable-type secondary battery LG CHEM, LTD. (KR) 2013-07-16 US claimed
US-20120156554-A1 Cable-Type Secondary Battery And Manufacturing Method Thereof LG CHEM, LTD. (KR) 2012-06-21 US claimed
US-20120148918-A1 ANODE OF CABLE-TYPE SECONDARY BATTERY AND MANUFACTURING METHOD THEREOF LG ENERGY SOLUTION, LTD. (KR) 2012-06-14 US claimed
US-20120135299-A1 CABLE-TYPE SECONDARY BATTERY LG ENERGY SOLUTION, LTD. (KR) 2012-05-31 US claimed
US-20120107658-A1 CABLE-TYPE SECONDARY BATTERY LG ENERGY SOLUTION, LTD. (KR) 2012-05-03 US claimed
US-12583966-B2 Curable resin, cured product thereof, resin composition, and method for producing curable resin MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2026-03-24 US disclosed
US-12573633-B2 Binder for anode of secondary battery, anode of secondary battery and secondary battery LG CHEM, LTD. (KR) 2026-03-10 US disclosed
EP-1018529-A1 Process for producing polycarbonates TEIJIN LIMITED (JP) 2000-07-12 EP disclosed
EP-0976773-A2 Process for producing a polycarbonate resin TEIJIN LIMITED (JP) 2000-02-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12583966-B2 Curable resin, cured product thereof, resin composition, and method for producing curable resin ARL1, ASH2L, SEM1 LTA4H 1117/4885TSHR 4148/4885CA4 1349/4885
US-12573633-B2 Binder for anode of secondary battery, anode of secondary battery and secondary battery SMCHD1, PCNA, MMAB LTA4H 3923/4885TSHR 2055/4885CA4 4527/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.